The COVAX Fantasy
What Next: TBD | Tech, power, and the future
00:00
Do You Think It Worked for You?
Fiser's latest earnings report showd that its fourth quarter sales more than doubled. The company says its coved vaccine should generate 32 billion dollars in sales this year. But there is an argument that these s of outside incentives actually speeded up the race to create a vacine.
Transcript
Play full episode
